111 Price to Sales Ratio 2018-2024 | YI

Historical PS ratio values for 111 (YI) over the last 10 years. The current P/S ratio for 111 as of February 07, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
111 P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-02-07 6.98 0.03
2024-09-30 0.76 $241.16 0.00
2024-06-30 1.07 $240.89 0.00
2024-03-31 1.16 $242.97 0.00
2023-12-31 1.55 $250.23 0.01
2023-09-30 2.60 $248.64 0.01
2023-06-30 2.46 $245.69 0.01
2023-03-31 2.65 $243.07 0.01
2022-12-31 3.02 $235.30 0.01
2022-09-30 2.68 $235.75 0.01
2022-06-30 2.06 $241.86 0.01
2022-03-31 2.66 $243.92 0.01
2021-12-31 3.50 $235.18 0.01
2021-09-30 6.17 $222.39 0.03
2021-06-30 9.09 $202.02 0.04
2021-03-31 13.80 $173.39 0.08
2020-12-31 6.95 $152.64 0.05
2020-09-30 6.20 $120.68 0.05
2020-06-30 6.35 $97.40 0.07
2020-03-31 6.61 $84.45 0.08
2019-12-31 6.73 $69.33 0.10
2019-09-30 4.87 $61.90 0.08
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.057B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.872B 57.28
Tempus AI (TEM) United States $10.232B 0.00
Hims & Hers Health (HIMS) United States $8.842B 224.83
Inspire Medical Systems (INSP) United States $5.430B 169.35
IRhythm Technologies (IRTC) United States $3.397B 0.00
Privia Health (PRVA) United States $2.723B 226.90
Enovis (ENOV) United States $2.544B 16.95
Azenta (AZTA) United States $2.469B 114.98
Clover Health Investments (CLOV) United States $2.225B 0.00
Schrodinger (SDGR) United States $1.886B 0.00
Omnicell (OMCL) United States $1.826B 39.83
10x Genomics (TXG) United States $1.773B 0.00
Phreesia (PHR) United States $1.680B 0.00
Butterfly Network (BFLY) United States $0.937B 0.00
Talkspace (TALK) United States $0.608B 0.00
Standard BioTools (LAB) United States $0.529B 0.00
Fulgent Genetics (FLGT) United States $0.507B 0.00
TruBridge (TBRG) United States $0.380B 110.57
Nyxoah SA (NYXH) Belgium $0.369B 0.00
Health Catalyst (HCAT) United States $0.334B 0.00
Pulmonx (LUNG) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
American Well (AMWL) United States $0.176B 0.00
EUDA Health Holdings (EUDA) Singapore $0.104B 0.00
MDxHealth SA (MDXH) Belgium $0.087B 0.00
P3 Health Partners (PIII) United States $0.073B 0.00
CareCloud (CCLD) United States $0.066B 0.00
HeartBeam (BEAT) United States $0.065B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
Outset Medical (OM) United States $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.043B 0.00
Zhongchao (ZCMD) China $0.037B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
MSP Recovery (MSPR) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00